CS McKee’s Zimmer Biomet ZBH Stock Holding History

CS McKee’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-299,847	Closed	-$30.2M	–	105
2014 Q2	$30.2M	Sell	299,847 -16,068	-5%	-$1.57M	0.64%	51
2014 Q1	$29M	Sell	315,915 -19,693	-6%	-$1.81M	0.62%	52
2013 Q4	$30.4M	Sell	335,608 -14,630	-4%	-$1.27M	0.59%	52
2013 Q3	$27.9M	Sell	350,238 -10,506	-3%	-$827K	0.47%	65
2013 Q2	$26.2M	Buy	+360,744	New	+$27M	0.45%	67

Other funds holding ZBH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

CS McKee's ZBH Position: Q3 2014 in Review

CS McKee sold out of Zimmer Biomet (ZBH) in Q3 2014, closing a stake of 299,847 shares — an estimated $30.2M sold.

CS McKee first reported a position in ZBH in Q2 2013 and held it in 5 quarters. The position peaked at $30.4M in Q4 2013. 720 funds tracked by Wall St. Rank hold ZBH as of Q3 2014.

CS McKee reported no remaining Zimmer Biomet position as of Q3 2014 after selling out during the quarter.
CS McKee sold 299,847 Zimmer Biomet shares in Q3 2014, an estimated $30.2M.
CS McKee first reported a position in Zimmer Biomet in Q2 2013 and held it in 5 quarters.
CS McKee's Zimmer Biomet position peaked at $30.4M in Q4 2013.
720 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2014.

Based on CS McKee's 13F filing for Q3 2014, filed 14 Nov 2014.